p53/D13S319/RB1/1q21/IGH基因探针

p53/D13S319/RB1/1q21/IGH基因探针

 广州健仑生物科技​有限公司 

本司长期供应尼古丁（可替宁）检测试剂盒，其主要品牌包括美国NovaBios、广州健仑、广州创仑等进口产品，国产产品，试剂盒的实验方法是胶体金方法。

我司还有很多荧光原位杂交系列检测试剂盒以及各种FISH基因探针和染色体探针等，。

p53/D13S319/RB1/1q21/IGH基因探针

   本试剂盒主要用于p53/D13S319/RB1/1q21/IGH基因的检测，里面包括即用型杂交液和DAPI复染剂。
本试剂盒仅供科研使用。

欢迎咨询

欢迎咨询

以下是我司出售的部分FISH产品：

二维码扫一扫

【公司名称】 广州健仑生物科技有限公司
【】    杨永汉 

【】
【腾讯 】
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室

【企业文化宣传】

This phase of the development of the vaccine was attributed to Louis Basudeb (Louis Pasteur) (Figure 2) in the late nineteenth Century in the field of vaccine development and the pioneering role of excellence. The great contribution of Pasteur, known as the father of vaccine, lies in that he chooses the pathogenic microorganism with strong immunogenicity to be cultured, physically and chemically deactivated, and then purified. The virulent strain of inactivated vaccine is generally virulent, but the attenuated and attenuated strain also has good immunogenicity, such as poliomyelitis inactivated vaccine produced by Sabin (Sabin) attenuated strain. Attenuated live vaccine is made by artificial directional mutation, or from natural selection of highly virulent or non-toxic living microorganism, and inoculated with it, so as to prevent infectious diseases.

At the end of the nineteenth Century, Koch (Koch) invented a method to isolate bacterial cultures on a solid medium, which laid the foundation for Pasteur to develop a vaccine. Pasteur first discovered that the growth toxicity of bacteria on the artificial medium decreased for a long time, such as Vibrio cholerae after two weeks. And the important thing is that if fresh Vibrio cholerae are used to attack the injected chickens, none of them will have cholera. Pasteur believes that this is due to the reduced virulence of Vibrio cholerae in the old culture, but the immunogenicity still exists, which makes chickens produce immunity against Vibrio cholerae. In this theory, two weeks after the culture of Bacillus anthracis in the environment of 42~43 C, a live attenuated anthrax vaccine was made.

In May 5, 1881, Pasteur chose 24 sheep, 1 goats and 6 cattle. The animals were vaccinated with anthrax vaccine and were immunized two times after 12 days with anthrax vaccine. In May 31st, the experimental group and the control group were attacked by pathogenic Bacillus anthracis. The results were as follows: (1) all sheep and goats died in the control group, 2 cows died and 4 cows were in serious condition. 2. Only 1 sheep died in the experimental group. The experimental results show that the anthrax vaccine has a protective effect on animals. Since the first formal use of the live attenuated anthrax vaccine in 1881, 85000 sheep were immunized at the beginning of 1882, and an unprecedented immune protection effect was achieved.

呢一阶段疫苗嘅发展归功于路易·巴斯德（Louis Pasteur）于十九世纪末喺疫苗研制领域嘅先锋作用同贡献。被誉为疫苗之父嘅巴斯德嘅伟大贡献在于：佢选用免疫原先性强嘅病原微生物经培养，用物理或者化学方法将其灭生之后，再经纯化做。冇生疫苗使用嘅毒种一般系强毒株，但使用减毒嘅弱毒株都有良好嘅免疫原先性，如用萨宾（Sabin）减毒株生产嘅脊髓灰质炎灭生疫苗。减毒生疫苗系采用人工定向变异嘅方法，或者喺自然界筛选出毒力高度减弱或者基本无毒嘅工作嘅微生物做疫苗，并以此畀人接种而去到预防惹病嘅目的。

喺十九世纪末，科赫（Koch）发明咗喺固体培养基上分离架嘛培养细菌物嘅方法，应该法为巴斯德研制疫苗奠定咗基础。巴斯德首先发现细菌喺人工培养基上长时间生长咗毒减弱，如放置两星期后嘅鸡霍乱弧菌，以此菌畀鸡仔打针后唔使鸡致病。而且重要嘅系：如果而且用新鲜嘅霍乱弧菌攻击啲已打针嘅鸡仔，佢哋都唔会发生霍乱。巴斯德认为呢系由于陈旧培养物中鸡霍乱弧菌嘅毒力减低，但免疫原先性依然系存在，因而令鸡仔惹咗针对霍乱弧菌嘅免疫力。以此理论巴斯德将炭疽杆菌喺42~43℃嘅环境下培养两星期后，做人工减毒炭疽生疫苗。

1881年5月5日巴斯德选择24头绵羊、1头山羊同6只牛实验。用炭疽疫苗接种啲动物，隔12天后而且用炭疽疫苗二次加强免疫。5月31日对实验组同对照组采用致病嘅炭疽杆菌攻击，结果系：①对照组绵羊同山羊全部死亡，2只牛死亡同4只牛病情伤；②试验组仅有1头绵羊死亡。实验说明炭疽结果疫苗对动物有保护作用。自1881年减毒炭疽生疫苗*次正式使用，到1882初，公司有85000头绵羊畀免疫，并获得咗*嘅免疫保护效果。